Clinical Study to Evaluate the Safety and Efficacy of γδ T Cells for the Prevention of Relapse After Allogeneic Transplantation in Patients With High-risk Acute Myeloid Leukemia
Conditions
- High-Risk Acute Myeloid Leukemia
Interventions
- BIOLOGICAL: allogeneic γδ T cell infusion
Sponsor
Donghua Zhang